scispace - formally typeset
C

Crystal C. Watkins

Researcher at Johns Hopkins University

Publications -  23
Citations -  1548

Crystal C. Watkins is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Nitric oxide synthase & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 14, co-authored 23 publications receiving 1428 citations. Previous affiliations of Crystal C. Watkins include Johns Hopkins University School of Medicine.

Papers
More filters
Journal ArticleDOI

Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes

TL;DR: DNA damage and a major activation of PARP in pancreatic islets of STZ-treated mice are demonstrated and PARP activation may participate in the pathophysiology of type I diabetes, for which PARP inhibitors might afford therapeutic benefit.
Journal ArticleDOI

Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy.

TL;DR: In diabetic animals, delayed gastric emptying can be reversed with a phosphodiesterase inhibitor, sildenafil, and these findings have implications for novel therapeutic approaches and may clarify the etiology of diabetic gastropathy.
Journal ArticleDOI

A Novel Neuron-Enriched Homolog of the Erythrocyte Membrane Cytoskeletal Protein 4.1

TL;DR: By analogy with the roles of4.1R in red blood cells, 4.1N may function to confer stability and plasticity to the neuronal membrane via interactions with multiple binding partners, including the spectrin-actin–based cytoskeleton, integral membrane channels and receptors, and membrane-associated guanylate kinases.
Journal ArticleDOI

Cognitive impairment in patients with AIDS - prevalence and severity.

TL;DR: The severity and prevalence of the neuropsychiatric complications of HIV including delirium, neurobehavioral impairments (depression), minor cognitive-motor dysfunction, and HIV-associated dementia are reviewed.
Journal ArticleDOI

Initial Evaluation of 11C-DPA-713, a Novel TSPO PET Ligand, in Humans

TL;DR: This initial study in humans shows that 11C-DPA-713 is a promising ligand for evaluating TSPO binding with PET, and dose-normalized time–activity curves showed that 12C-N,N-diethyl-2-[2-(4-methoxyphenyl)-5,7-dimethyl-pyrazolo]pyrimidin-3-yl]-acetamide gives a larger brain signal.